STOCK TITAN

Paul Jones Appointed as Senior Project Manager at Jupiter Wellness

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Jupiter Wellness (NASDAQ: JUPW) announced the appointment of Paul Jones as Senior Project Manager on June 2, 2022. With over 20 years of experience, Jones previously managed projects at a South Florida investment firm and was part of Ferrari’s project management team. His expertise will enhance Jupiter's product pipeline for skincare therapeutics, incorporating cannabidiol (CBD) for conditions like psoriasis and skin cancer. The company continues to expand its proprietary skincare products, aiming to maximize growth and development.

Positive
  • Appointment of Paul Jones as Senior Project Manager to enhance project management capabilities.
  • Jones brings over 20 years of experience, including significant roles in high-profile companies like Ferrari.
  • Jupiter's focus on expanding its product pipeline for cannabinoid-based skincare therapeutics.
Negative
  • None.

JUPITER, FL / ACCESSWIRE / June 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Paul Jones has joined Jupiter Wellness as Senior Project Manager.

Paul joins Jupiter Wellness with over 20 years of experience building and directing operations, implementing improvements and overseeing projects in a wide range of industries.

Most recently he was Project Manager in an Investment and Management Company with operations in South Florida and Italy. He was responsible for initiating projects in the US and Italy, managing costs, timelines, and project performance from initiation through completion.

From 2004 - 2011 he was part of the project management team at Ferrari headquarters in Maranello, Italy where he headed the Design Production Team for Ferrari and Maserati.

"We are extremely excited to add someone of Paul's caliber to the Jupiter Wellness Team. With our rapid growth, he will be an integral part of our team managing and maximizing our product pipeline both for the consumer products and new products in in scientific development ." Stated Dr. Glynn Wilson, CSO and Chairman.

About Jupiter Wellness
Jupiter Wellness, Inc. (NASDAQ:JUPW) is a leading developer of pharmaceutical cannabinoids focused on skincare therapeutics and treatments. The Company's product pipeline incorporates cannabidiol (CBD) to address indications including psoriasis, eczema, burns, herpes cold sores, and skin cancer. Jupiter generates revenue from a growing line of proprietary over-the-counter skincare products including its CaniSun™ sunscreen and other wellness brands sold through www.cbdcaring.com. For additional information, please visit www.jupiterwellness.com.

Jupiter Wellness Media Contact:

Phone: 561-244-7100
Email: info@JupiterWellness.com

Forward Looking Statements

This communication contains forward-looking statements regarding Jupiter Wellness, including, the anticipated timing of studies and the results and benefits thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "explore," "evaluate," "intend," "may," "might," "plan," "potential," "predict," "project," "seek," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are based on each of the Company's current plans, objectives, estimates, expectations, and intentions and inherently involve significant risks and uncertainties, many of which are beyond Jupiter Wellness' control. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Jupiter Wellness and, including those described from time to time under the caption "Risk Factors" and elsewhere in Jupiter Wellness' Securities and Exchange Commission (SEC) filings and reports, including Jupiter Wellness' Annual Report on Form 10-K for the year ended December 31, 2021 and future filings and reports by Jupiter Wellness. Moreover, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies' forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at such dates, even if they are subsequently made available by Jupiter Wellness on its website or otherwise. Jupiter Wellness undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made.

SOURCE: Jupiter Wellness, Inc.



View source version on accesswire.com:
https://www.accesswire.com/703583/Paul-Jones-Appointed-as-Senior-Project-Manager-at-Jupiter-Wellness

FAQ

Who is the new Senior Project Manager at Jupiter Wellness?

Paul Jones has been appointed as the Senior Project Manager at Jupiter Wellness.

What experience does Paul Jones have?

Paul Jones has over 20 years of experience, including project management roles at a South Florida investment firm and at Ferrari.

What is Jupiter Wellness focusing on with its new product pipeline?

Jupiter Wellness is focusing on skincare therapeutics using cannabidiol (CBD) for various skin conditions.

What is the stock ticker for Jupiter Wellness?

The stock ticker for Jupiter Wellness is JUPW.

When was Paul Jones appointed at Jupiter Wellness?

Paul Jones was appointed as Senior Project Manager on June 2, 2022.

Jupiter Wellness, Inc.

NASDAQ:JUPW

JUPW Rankings

JUPW Latest News

JUPW Stock Data

49.33M
9.02M
44.96%
18.71%
7.54%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Jupiter